Literature DB >> 30927257

Protective effects of microRNA-22-3p against retinal pigment epithelial inflammatory damage by targeting NLRP3 inflammasome.

Zizhong Hu1, Xuehua Lv1,2, Lu Chen1, Xunyi Gu1, Huiming Qian1, Silvia Fransisca1, Zhengyu Zhang1, Qinghuai Liu1, Ping Xie1.   

Abstract

NLRP3, as a crucial inflammasome component, plays important roles in age-related macular degeneration. Though some activators of NLRP3 have been studied, microRNAs (miRNAs) which potentially regulate NLRP3 messenger RNA (mRNA) have not been fully explored in retinal pigment epithelial (RPE) cells and retinopathy. In this study, by miRNA microarray profiling and bioinformatic analysis, we identified that four miRNAs, miR-4286, miR-223-3p, miR-365a, miR-22-3p, may target NLRP3 mRNA in RPE inflammatory damage in vivo. Further, real-time polymerase chain reaction verified that only miR-22-3p was significantly decreased, which was associated with NLRP3 upregulation in blue-light-induced retinopathy. Mechanistically, the dual-fluorescent reporter suggested miR-22-3p directly binds NLRP3 mRNA. Moreover, overexpression of miR-22-3p could significantly reduce whereas inhibition miR-22-3p could increase the mRNA and protein expressions of NLRP3, Caspase-1, and mature IL-1β. Collectively, our results indicate that miR-22-3p plays a suppressive role in RPE damage by targeting NLRP3, which provides new insights into the future intervention to retinopathy.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  NLRP3; miR-22-3p; retinal pigment epithelia; retinopathy

Mesh:

Substances:

Year:  2019        PMID: 30927257     DOI: 10.1002/jcp.28523

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  15 in total

Review 1.  Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases.

Authors:  Meini Chen; Rong Rong; Xiaobo Xia
Journal:  J Neuroinflammation       Date:  2022-07-14       Impact factor: 9.587

Review 2.  MicroRNA regulation of critical retinal pigment epithelial functions.

Authors:  Samuel W Du; Krzysztof Palczewski
Journal:  Trends Neurosci       Date:  2021-11-06       Impact factor: 16.978

3.  LncRNA Neat1 expedites the progression of liver fibrosis in mice through targeting miR-148a-3p and miR-22-3p to upregulate Cyth3.

Authors:  Wei Huang; Feizhou Huang; Rui Zhang; Hongwu Luo
Journal:  Cell Cycle       Date:  2021-02-08       Impact factor: 4.534

4.  MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome.

Authors:  Hanying Ding; Jinxiang Li; Yang Li; Minliang Yang; Sheng Nie; Miaomiao Zhou; Zhanmei Zhou; Xiaobing Yang; Youhua Liu; Fan Fan Hou
Journal:  Mol Ther       Date:  2021-03-17       Impact factor: 12.910

5.  The reduction of XIAP is associated with inflammasome activation in RPE: implications for AMD pathogenesis.

Authors:  Jiangyuan Gao; Jing Z Cui; Aikun Wang; Hao Hang Rachel Chen; Alison Fong; Joanne A Matsubara
Journal:  J Neuroinflammation       Date:  2019-08-22       Impact factor: 8.322

6.  Cannabinoid Receptor 1/miR-30b-5p Axis Governs Macrophage NLRP3 Expression and Inflammasome Activation in Liver Inflammatory Disease.

Authors:  Le Yang; Lei Tian; Zhi Zhang; Xuan Zhou; Xiaofang Ji; Fuquan Liu; Chengbin Dong; Lei Hou; Xinhao Zhao; Na Chang; Lin Yang; Liying Li
Journal:  Mol Ther Nucleic Acids       Date:  2020-04-28       Impact factor: 8.886

7.  Identification of Diagnostic and Prognostic microRNAs for Recurrent Vitreous Hemorrhage in Patients with Proliferative Diabetic Retinopathy.

Authors:  Parviz Mammadzada; Juliette Bayle; Johann Gudmundsson; Anders Kvanta; Helder André
Journal:  J Clin Med       Date:  2019-12-15       Impact factor: 4.241

8.  MicroRNA-302c-3p inhibits endothelial cell pyroptosis via directly targeting NOD-, LRR- and pyrin domain-containing protein 3 in atherosclerosis.

Authors:  Baochen Bai; Yanyan Yang; Shengxiang Ji; Shizhong Wang; Xingang Peng; Chao Tian; Rui-Cong Sun; Tao Yu; Xian-Ming Chu
Journal:  J Cell Mol Med       Date:  2021-03-30       Impact factor: 5.310

9.  Expression of miRNA-223 and NLRP3 gene in IgA patients and intervention of traditional Chinese medicine.

Authors:  Liqi Li; Zhaoyong Gong; Piliang Xue; Dandan Wang; Meixiu Xu; Shumei Sui; Liya Li
Journal:  Saudi J Biol Sci       Date:  2020-04-25       Impact factor: 4.219

10.  LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.

Authors:  Niansheng Ren; Tao Jiang; Chengbo Wang; Shilin Xie; Yanwei Xing; Daxun Piao; Tiemin Zhang; Yuekun Zhu
Journal:  Aging (Albany NY)       Date:  2020-06-09       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.